Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma

The extremely poor prognosis of patients with symptomatic hepatocellular carcinoma (HCC) diagnosed clinically at advanced stages suggests an urgent need for biomarkers that can be used for prospective surveillance and pre-clinical screening for early presence of pre-malignant lesions and tumors. In...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Lett
Main Authors: Li, Liang, Chen, Jianguo, Chen, Xin, Tang, Jing, Guo, Huan, Wang, Xiaofeng, Qian, Ji, Luo, Guijuan, He, Fangping, Lu, Xiaomei, Ding, Yibo, Yang, Yingchen, Huang, Wentao, Hou, Guojun, Lin, Ximeng, Ouyang, Qin, Li, Hengyu, Wang, Ruoyu, Jiang, Feng, Pu, Rui, Lu, Jianhua, Jin, Mudan, Tan, Yexiong, Gonzalez, Frank J., Cao, Guangwen, Wu, Mengchao, Wen, Hao, Wu, Tangchun, Jin, Li, Chen, Lei, Wang, Hongyang
פורמט: Artigo
שפה:Inglês
יצא לאור: 2016
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594104/
https://ncbi.nlm.nih.gov/pubmed/26850373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2016.01.028
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים